Relapsed or refractory anaplastic large-cell lymphoma in children and adolescents after Berlin-Frankfurt-Muenster (BFM)-type first-line therapy: A BFM-Group study

Journal of Clinical Oncology

Volumn 29, Issue 22, 2011, Pages 3065-3071

  Woessmann, Willi ^a   Zimmermann, Martin ^a   Lenhard, Meike ^a   Burkhardt, Birgit ^a   Rossig, Claudia ^b   Kremens, Bernhard ^c   Lang, Peter ^d   Attarbaschi, Andishe ^f   Mann, Georg ^f   Oschlies, Ilske ^e   Klapper, Wolfram ^e   Reiter, Alfred ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

^d UNIVERSITY OF TÜBINGEN   (Germany)

^e UNIVERSITY OF KIEL   (Germany)

^f ST ANNA CHILDREN S HOSPITAL   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CARMUSTINE; CD3 ANTIGEN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; ETOPOSIDE; MELPHALAN; ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; ADVANCED CANCER; ANTIGEN EXPRESSION; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RELAPSE; CHILD; CLINICAL PROTOCOL; COHORT ANALYSIS; CORRELATION ANALYSIS; EVENT FREE SURVIVAL; FOLLOW UP; HUMAN; HUMAN TISSUE; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; NEWBORN; OVERALL SURVIVAL; PRIORITY JOURNAL; RISK FACTOR; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT RESPONSE; WHOLE BODY RADIATION; AUTOTRANSPLANTATION; DISEASE FREE SURVIVAL; FEASIBILITY STUDY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MALE; METHODOLOGY; PREDICTIVE VALUE; PRESCHOOL CHILD; PROGNOSIS; RECURRENT DISEASE; REMISSION; RISK ASSESSMENT; SALVAGE THERAPY;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEASIBILITY STUDIES; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LYMPHOMA, LARGE-CELL, ANAPLASTIC; MALE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECURRENCE; REMISSION INDUCTION; RISK ASSESSMENT; RISK FACTORS; SALVAGE THERAPY; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 80051615739     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.34.8417     Document Type: Article

References (29)

1. Brugieres L, Le Deley MC, Rosolen A, et al: Impact of the methotrexate administration dose on the need for intrathecal treatment in children and adolescents with anaplastic large-cell lymphoma: Results of a randomized trial of the EICNHL Group. J Clin Oncol 27:897-903, 2009
2. Le Deley MC, Rosolen A, Williams DM, et al: Vinblastine in children and adolescents with highrisk anaplastic large-cell lymphoma: Results of the randomized ALCL99-vinblastine trial. J Clin Oncol 28:3987-3993, 2010
3. Reiter A, Schrappe M, Tiemann M, et al: Successful treatment strategy for Ki-1 anaplastic large-cell lymphoma of childhood: A prospective analysis of 62 patients enrolled in three consecutive Berlin-Frankfurt-Munster group studies. J Clin Oncol 12:899-908, 1994 (Pubitemid 24145315)
4. Reiter A, Schrappe M, Parwaresch R, et al: Non-Hodgkin's lymphomas of childhood and adolescence: Results of a treatment stratified for biologic subtypes and stage - A report of the Berlin-Frankfurt-Munster Group. J Clin Oncol 13:359-372, 1995
5. Seidemann K, Tiemann M, Schrappe M, et al: Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: A report of the Berlin-Frankfurt-Munster Group Trial NHL-BFM 90. Blood 97:3699-3706, 2001
6. Brugieres L, Quartier P, Le Deley MC, et al: Relapses of childhood anaplastic large-cell lymphoma: Treatment results in a series of 41 children - A report from the French Society of Pediatric Oncology. Ann Oncol 11:53-58, 2000 (Pubitemid 30084579)
7. Brugieres L, Pacquement H, Le Deley MC, et al: Single-drug vinblastine as salvage treatment for refractory or relapsed anaplastic large-cell lymphoma: A report from the French Society of Pediatric Oncology. J Clin Oncol 27:5056-5061, 2009
8. Gross TG, Hale GA, He W, et al: Hematopoietic stem cell transplantation for refractory or recurrent non-Hodgkin lymphoma in children and adolescents. Biol Blood Marrow Transplant 16:223-230, 2010
9. Mori T, Takimoto T, Katano N, et al: Recurrent childhood anaplastic large cell lymphoma: A retrospective analysis of registered cases in Japan. Br J Haematol 132:594-597, 2006 (Pubitemid 43381592)
10. Stockklausner C, Behnisch W, Mechtersheimer G, et al: Long-term remission of children with relapsed and secondary anaplastic large cell non-Hodgkin lymphoma (ALCL) following treatment with pulsed dexamethasone and low dose etoposide. Pediatr Blood Cancer 50:126-129, 2008 (Pubitemid 350234279)
11. Williams DM, Hobson R, Imeson J, et al: Anaplastic large cell lymphoma in childhood: Analysis of 72 patients treated on The United Kingdom Children's Cancer Study Group chemotherapy regimens. Br J Haematol 117:812-820, 2002 (Pubitemid 34639241)
12. Woessmann W, Peters C, Lenhard M, et al: Allogeneic haematopoietic stem cell transplantation in relapsed or refractory anaplastic large cell lymphoma of children and adolescents: A Berlin-Frankfurt-Munster group report. Br J Haematol 133:176-182, 2006
13. Mori T, Kiyokawa N, Shimada H, et al: Anaplastic large cell lymphoma in Japanese children: Retrospective analysis of 34 patients diagnosed at the National Research Institute for Child Health and Development. Br J Haematol 121:94-96, 2003 (Pubitemid 36461272)
14. Delsol G, Falini B, Mueller-Hermelink K, et al: Anaplastic large cell lymphoma, ALK-positive, in World Health Organization (WHO) Classification of Tumours of Haematopoietic and Lymphoid Tissues (ed 4). Lyon, France, IARC Press, 2008, pp 312-316
15. Brugieres L, Deley MC, Pacquement H, et al: CD30+ anaplastic large-cell lymphoma in children: Analysis of 82 patients enrolled in two consecutive studies of the French Society of Pediatric Oncology. Blood 92:3591-3598, 1998 (Pubitemid 28525184)
16. Rosolen A, Pillon M, Garaventa A, et al: Anaplastic large cell lymphoma treated with a leukemia-like therapy: Report of the Italian Association of Pediatric Hematology and Oncology (AIEOP) LNH-92 protocol. Cancer 104:2133-2140, 2005 (Pubitemid 41579959)
17. Woessmann W, Oschlies I, Mann G, et al: Intensification with HD-MTX, HD-Arac/VP-16 did not improve the outcome of high risk pediatric ALCL: Results from the trial NHL-BFM95. J Pediatr Hematol Oncol 25:S4, 2003 (suppl; abstr)
18. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
19. Kalbfleisch JD, Prentice RL: The Statistical Analysis of Failure Time Data. New York, NY, John Wiley & Sons, 1980
20. Gray RJ: A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 16:1141-1154, 1988
21. Kyriakou C, Canals C, Finke J, et al: Allogeneic stem cell transplantation is able to induce long-term remissions in angioimmunoblastic T-cell lymphoma: A retrospective study from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. J Clin Oncol 27:3951-3958, 2009
22. Le GS, Milpied N, Buzyn A, et al: Graft-versus-lymphoma effect for aggressive T-cell lymphomas in adults: A study by the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire. J Clin Oncol 26:2264-2271, 2008
23. Burkhardt B, Reiter A, Landmann E, et al: Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: A report from the Berlin-Frankfurt-Muenster group. J Clin Oncol 27:3363-3369, 2009
24. Schrauder A, Reiter A, Gadner H, et al: Superiority of allogeneic hematopoietic stem-cell transplantation compared with chemotherapy alone in high-risk childhood T-cell acute lymphoblastic leukemia: Results from ALL-BFM 90 and 95. J Clin Oncol 24:5742-5749, 2006 (Pubitemid 46631317)
25. Le Deley MC, Reiter A, Williams D, et al: Prognostic factors in childhood anaplastic large cell lymphoma: Results of a large European intergroup study. Blood 111:1560-1566, 2008 (Pubitemid 351213446)
26. Ait-Tahar K, Damm-Welk C, Burkhardt B, et al: Correlation of the autoantibody response to the ALK oncoantigen in pediatric anaplastic lymphoma kinase-positive anaplastic large cell lymphoma with tumor dissemination and relapse risk. Blood 115:3314-3319, 2010
27. Damm-Welk C, Busch K, Burkhardt B, et al: Prognostic significance of circulating tumor cells in bone marrow or peripheral blood as detected by qualitative and quantitative PCR in pediatric NPM-ALK-positive anaplastic large-cell lymphoma. Blood 110:670-677, 2007 (Pubitemid 47105406)
28. Mussolin L, Pillon M, d'Amore ES, et al: Prevalence and clinical implications of bone marrow involvement in pediatric anaplastic large cell lymphoma. Leukemia 19:1643-1647, 2005 (Pubitemid 43090410)
29. Mussolin L, Bonvini P, Ait-Tahar K, et al: Kinetics of humoral response to ALK and its relationship with minimal residual disease in pediatric ALCL. Leukemia 23:400-402, 2009